Omid Veiseh is a researcher working on engineered cell-based bioelectronic implants to monitor tumor environments and produce personalized immunotherapies and biologics.
Referenced in coverage
“Co-led development of HOBIT implantable living pharmacy system for chronic disease treatment.”